The Book of Pharmaceutical & Healthcare Lists by Unknown

Author:Unknown
Language: eng
Format: epub
Publisher: ILM Publications
Published: 2015-06-08T16:00:00+00:00

Source: Center for Financing, Access, and Cost Trends, AHRQ, Household Component of the Medical Expenditure Panel Survey, 1996 and 2006. STATISTICAL BRIEF #235: Trends in Outpatient Prescription Analgesics Utilization and Expenditures for the U.S. Civilian Non-institutionalized Population, 1996 and 2006 Table 4.23. Arthritis Agents: Use and Expenditures, 2005 Percentage reporting arthritis, by sex and by race/ethnicity Total

Percentage 9.5% By sex By race/ethnicity

White Black Asian Male Female Hispanic nonnonnonOther Hispanic Hispanic Hispanic 7.1% 11.9% 5.9% 10.5% 9.7% 4.3% 13.1%

Dollars Mean expenditures on arthritis per person with expense for given service type Total $1513

Ambulatory care visits Prescription medications $705 $508

Percentage

Percentage distribution of expenditures on arthritis, by type of service (Total expenditures = $32 billion) Ambulatory 35.6% ER Prescriptions 0.7% 21.3% In-patient 30.8% Home Health 11.6%

Percentage

Percentage of total arthritis expenditures from out of pocket ER PMED 13.7% 51.1% Total Ambulatory Hospital stays 17.5% 13.0% 4.1% Home visits

5.8%

Percentage Percentage of arthritis expenditures by type of service PMED 63.4%

Ambulatory Hospital stays ER 76.3% 2.6% 2.3% Home visits 4.7% Source: Center for Financing, Access, and Cost Trends, AHRQ, Household Component of the Medical Expenditure Panel Survey, 2005. STATISTICAL BRIEF #222: Arthritis: Use and Expenditures among U.S. Adult Non-institutionalized Population, 2005

http://www.meps.ahrq.gov/mepsweb/data_files/publications/st222/stat222.shtml

Table 4.24. Attention-Deficit Hyperactivity Disorder (ADHD) Agents: Use and Expenditures in Children Ages 5-17, 2007

Prescription Total Ambulatory Medications Billions of dollars $3.6 $0.8 $2.3 Mean per person expenditures $1319 $427 $902 By source of payment and type of service

Private 29.5% 40.9% 32.6% Medicaid 47.0% 36.5% 38.1% Out-of-pocket 17.6% 14.8% 22.9% Other 5.9% 7.8% 6.4%

Source: Center for Financing, Access, and Cost Trends, AHRQ, Household Component of the Medical Expenditure Panel Survey, 2007 STATISTICAL BRIEF #276: Attention-Deficit Hyperactivity Disorder (ADHD) in Children, Ages 5-17: Use and Expenditures, 2007

Table 4.25. Diabetes Management: Tests, Treatments and Trends, 2007 Total 18-64 65+ Men Women Percentage of adults with reported diagnosed diabetes, by age and sex

7.4 5.2 18.3 7.4 7.3 Hispanic Black nonHispanic White nonHispanic Other

Percentage of adults with reported diagnosed diabetes, by 7.2race/ethnicity

9.6 7.1 5.9

All tests No tests 1 or 2 tests Don’t know

Distribution of adult diabetics receiving recommended 32.9% 3.3% 57.7% diabetes tests

6.1%

Percentage of adult diabetics receiving recommended diabetes tests, by race/ethnicity

Percentage Hispanic

Non-Hispanic White Non-Hispanic Black

Other

All 3 tests 1-2 tests 22.3 59.4 36.5 56.2 25.7 65.1 36.3 50.4 No tests 8.2

2.4

3.3

2.0

Don’t know 10.1

4.9

5.9

11.3

All 3 tests None Diet modification Oral medications Insulin Percentage of adult diabetics using diabetes management/treatment methods

11.5 1.2 80.8 78.8 24.1

Percentage of adult diabetics using diabetes management/treatment methods, by race/ethnicity

Percentage Hispanic

Non-Hispanic White Non-Hispanic Black

Other

Percentage of persons with comorbid conditions, among persons reporting treatment for diabetes Diet modification

84.0

80.4

81.5

74.9

Cardiovascular disease 17.2

Oral medications 83.8

78.1

77.4

80.3

Hypertension 64.8

Insulin

21.4

22.5

33.5

24.6

Hyperlipidemia

52.8

Orals Insulin Non-insulin injections Percentage of persons using orals, insulin, or non-insulin injections, among persons reporting treatment for diabetes

77.3 24.4 4.1 Percentage of persons using specific classes of oral anti-diabetic medications, among persons reporting treatment for diabetes

Sulfonylureas Biguanides Thiazolidinediones 40.2 55.2 24.6

Table 4.25. Diabetes Management: Tests, Treatments and Trends, 2007 - Continued

Expenditure on anti-diabetic medications, among persons reporting treatment for diabetes (2006-2007) All

therapeutic Sulfonylureas Biguanides Thiazolidinediones classes

Insulin Non-insulin Combinationsinjections

Per user expenditure Per user outof-pocket

expenditure

$944 $211 $297 $1121 $918

Download

Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.